Use of human amniotic membrane repair of anterior urethral defect: First clinical report

Authors:

Abstract
Objective: To evaluate the use of human amniotic membrane allograft to prevent urethrocutaneous fistula after tubularized incised plate repair for redo‐hypospadias and anterior urethral defects.Methods: This pilot study included 28 patients (mean age 25.3 ± 11 years) with a history of previous failed hypospadia repair, who underwent tubularized incised plate urethroplasty in one session by the same surgical team from April 2016 to April 2019. After the reconstruction of a neourethra and proper hemostasis, a human amniotic membrane allograft – Grafting Scaffold – was used to cover the suture lines.Results: The mean follow‐up time was 13.3 ± 4.5 months. Two urethrocutaneous fistulas occurred within the first 2 weeks after the surgery, one of which was caused by the infection of the surgical site. No penile torsion, urethral diverticula, meatal stenosis or glans dehiscence was reported.Conclusions: Amniotic membrane graft provides an applicable, low‐cost, feasible, biodegradable and safe second cover in redo‐hypospadias repairs by tubularized incised plate technique. Its use is technically easy; it has satisfactory cosmetic outcomes and might decrease urethrocutaneous fistula formation.

This publication has 24 references indexed in Scilit: